20.200
+0,00%
2026-10-14
Fundamental Analysis
65 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -12.8% | +199.6% | 1 / 3 | +23.6% | +0.30 pp | -1.65 pp | +21.7% | 1.26 | 5.27 | 276 | +23,6% | 10,9 | −12,8% | 5.27 | 7.75 | −32,0% |
| Pts | 0 | 12 | 4 | 12 | 8 | 4 | 12 | 6 | 12 | |||||||
Valuation annotation:Price: 20.200 (close price on 2026-10-14)EPS (TTM): 3.836
Financial charts
1.Revenue & growth
VND bn276Q2/26
1.Revenue & growth
VND bn276Q2/26
2.Profit & growth
VND bn10,9Q2/26
3.Profit mix (Penman)
VND bn126Q2/26
4.Margins & cost structure
%8.5%Q2/26
5.Returns & cash cycle
% · days5.9%Q2/26
6.Earnings quality & cash
VND bn-24,8Q2/26
7.Asset structure
VND bn1.614Q2/26
8.Funding & debt health
VND bn · times1.614Q2/26
9.Revenue backlog
VND bn84,7Q2/26
10.Valuation
times · %5,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %352Q2/26
Adjusted EPS growth, latest quarter
-12.8%
Average adjusted EPS growth, 3 quarters
200%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26